Decoy Therapeutics (DCOY) Assets Average (2015 - 2026)
Decoy Therapeutics (DCOY) posted quarterly Assets Average of $9.7 million for Q1 2026, up 263.27% year-over-year from $2.7 million in Q1 2025, and up 13.56% quarter-over-quarter from $8.6 million in Q4 2025.
Decoy Therapeutics (DCOY) Assets Average (2015 - 2026) Analysis & Trends
Decoy Therapeutics (DCOY) has reported Assets Average for 12 consecutive years, with $9.7 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Assets Average rose 263.27% year-over-year to $9.7 million; the TTM figure through Mar 2026 stood at $9.7 million (up 263.27% YoY), while the FY2025 annual figure was $7.0 million, up 46.52% from the prior year.
- Assets Average climbed to $9.7 million in Q1 2026 per DCOY's latest filing, from $8.6 million in the prior quarter.
- Across five years, Assets Average topped out at $38.2 million in Q1 2022 and bottomed at $1.9 million in Q2 2025.
- Historically, Assets Average has averaged $11.9 million across 5 years, with a median of $8.6 million in 2025.
- Annual changes were most pronounced in 2023 — Assets Average plunged 68.03% — and 2026, when it surged 263.27%.
- Decoy Therapeutics' Assets Average stood at $17.2 million in 2022, then plunged by 56.39% to $7.5 million in 2023, then tumbled by 54.09% to $3.4 million in 2024, then soared by 149.25% to $8.6 million in 2025, then advanced by 13.56% to $9.7 million in 2026.
- Business Quant data shows DCOY's Assets Average at $9.7 million in Q1 2026, $8.6 million in Q4 2025, and $3.7 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | 26.95 Bn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 41.30 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | - |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | 11.22 Bn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 8.86 Bn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 5.34 Bn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | 2.09 Bn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 19.82 Bn |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | 25.27 Bn |
| 10 | Decoy Therapeutics | 1.82 Mn | 1.82 Mn | - | 8.71 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 8.71 Mn |
| Mar 31, 2026 | 9.74 Mn |
| Dec 31, 2025 | 8.58 Mn |
| Sep 30, 2025 | 3.74 Mn |
| Jun 30, 2025 | 1.87 Mn |
| Mar 31, 2025 | 2.68 Mn |
| Dec 31, 2024 | 3.44 Mn |
| Sep 30, 2024 | 3.71 Mn |
| Jun 30, 2024 | 4.22 Mn |
| Mar 31, 2024 | 5.74 Mn |
| Dec 31, 2023 | 7.50 Mn |
| Sep 30, 2023 | 10.23 Mn |
| Jun 30, 2023 | 11.06 Mn |
| Mar 31, 2023 | 12.35 Mn |
| Dec 31, 2022 | 17.19 Mn |
| Sep 30, 2022 | 26.69 Mn |
| Jun 30, 2022 | 34.58 Mn |
| Mar 31, 2022 | 38.17 Mn |
| Dec 31, 2021 | 42.55 Mn |
| Sep 30, 2021 | 45.83 Mn |